Warning (2) : Trying to access array offset on value of type bool [in /home/appsemql/geetmark.com/templates/News/article.php, line 68]
|
...
CNBC
CNBC
3 weeks ago

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

The high-dose Wegovy helped patients with obesity lose an average 20.7% of their weight after 72 weeks in a phase three trial.